Document and Entity Information
Document and Entity Information | Jan. 10, 2022 |
Document And Entity Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | Jan. 10, 2022 |
Entity Registrant Name | Gemini Therapeutics, Inc. /DE |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39438 |
Entity Tax Identification Number | 85-1612845 |
City Area Code | 617 |
Local Phone Number | 401-4400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | GMTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001816736 |
Amendment Flag | false |
Former Address [Member] | |
Document And Entity Information [Line Items] | |
Entity Address, Address Line One | 300 One Kendall Square |
Entity Address, Address Line Two | 3rd Floor |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02139 |